Imaging and neurocircuitry of pediatric major depression

Clinical Neuropsychiatry

Volumn 3, Issue 3, 2006, Pages 219-229

  Rosenberg, David R ^a,b   MacMaster, Frank P ^a,b   Mirza, Yousha ^a,b   Easter, Phillip C ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Major depressive disorder; Neurobiology; Pediatric Depression

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; CHILDHOOD DISEASE; ELECTROCONVULSIVE THERAPY; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; HYPOPHYSIS; MAJOR DEPRESSION; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROIMAGING; OBSESSIVE COMPULSIVE DISORDER; PSYCHOTHERAPY; REVIEW; VOLUMETRY;

EID: 33845438063     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Aggleton JP (1992). The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. Wiley-Liss, New York.
2. Altamura CA, Mauri MC, Ferrara A, et al (1993). Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry 150, 1731-1733.
3. Altamura CA, Maes M, Dai J, et al (1995). Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. Eur Neuropsychopharmacol S, 71-75.
4. Angold A, Messer SC, Stangl D, et al (1998). Perceived parental burden and service use for child and adolescent psychiatric disorders. Am J Public Health 88, 75-80.
5. Arias E, MacDorman MF, Strobino DM, et al (2003). Annual summary of vital statistics - 2002. Pediatrics 112, 1215-1230.
6. Auer DP, Putz B, Kraft E et al (2000). Reduced glutamate in the anterior cingulate cortex in depression: An in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47, 305-313.
7. Barker P, Breiter S, Soher B, et al (1994). Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations. Magn Reson Med 32, 157-163.
8. Becquet D, Faudon M, Hery F (1990). In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: Involvement of GABA neurons. Brain Res 519, 82-88.
9. Bench CJ, Frackowiak RS, Dolan RJ (1995). Changes in regional cerebral blood flow on recovery from depression. Psychol Med 25, 247-261.
10. Birken DL, Oldendorf WH (1989). N-acetyl-L-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain (Review). Neurosci Biobehavior Rev 13, 23-31.
11. Birmaher B, Ryan ND, Williamson DE, et al (1996a). Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry 35, 12, 1575-83.
12. Birmaher B, Ryan ND, Williamson DE, et al (1996b). Childhood and Adolescent Depression: A review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 35, 427-1439.
13. Birmaher B, Kaufman J, Brent DA, et al (1997). Neuroendocrine response to 5-hydroxy-L-tryptophan in prepubertal children at high risk of major depressive disorder. Arch Gen Psychiatry 54, 1113-9.
14. Birmaher B, Dahl RE, Williamson DE, et al (2000). Growth hormone secretion in children and adolescents at high risk for major depressive disorder. Arch Gen Psychiatry 57, 867-72.
15. Botteron KN, Raichle ME, Drevets WC, et al (2002). Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol Psychiatry 51, 342-344.
16. Bremner JD, Narayan M, Anderson ER, et al (2000). Hippocampal volume reduction in major depression. Am J Psychiatry 157, 1, 115-8.
17. Brent DA, Moritz G, Bridge J, et al (1996). The impact of adolescent suicide on siblings and parents: A longitudinal follow-up. Suicide Life Threat Behav 26, 253-259.
18. Brent DA, Birmaher B (2004). British warnings on SSRI's questioned. J Am Acad Child Adolesc Psychiatry [letter] 43, 379-380.
19. Brady AI, Saxena S, Stoessel P, et al (2001). Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: Preliminary findings. Arch Gen Psychiatry 158, 631-640.
20. Charles HC, Lazeyras F, Krishnan KR, et al (1994). Brain choline in depression: In vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry 18, 1121-1127.
21. Coppen A (1967). The biochemistry of affective disorders. Br J Psychiatry 113, 1237-1264.
22. Cousins JP, Harper G (1996). Neurobiochemical changes from Taxol/ Neupogen chemotherapy for metastatic breast carcinoma corresponds with suicidal depression. Cancer Lett 110, 163-167.
23. Davidson, RJ. Irwin, W (1999). The functional neuroanatomy of emotion and affective style. Trends Cogn Sci 3, 11-21.
24. Davis M (1994). The role of the amygdala in emotional learning. Int Rev Neurobio 36, 225-266.
25. De Bellis MD, Casey BJ, Dahl RE, et al (2000). A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol Psychiatry 48, 51-57.
26. Dinc H, Esen F, Demirci A, et al (1998). Pituitary dimensions and volume measurements in pregnancy and post partum, MR assessment. Acta Radiol 39, 64-9.
27. Drevets WC, Videen TO, Price JL, et al (1992). A functional anatomical study of unipolar depression. J Neurosci 12, 3628-3641.
28. Drevets WC, Price JL, Simpson JR, et al (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 827.
29. Drevets WC (1998). Functional neuroimaging studies of depression: The anatomy of melancholia. Annu Rev Med 49, 341-361.
30. Drevets WC (2000). Neuroimaging studies of mood disorders. Biol Psychiatry 48, 813.
31. Ebert D, Ebmeier KP (1996). The role of the cingulate gyrus in depression-from functional anatomy to neurochemistry. Biol Psychiatry 39, 1044-1050.
32. El Mansari M, Bouchard C, Blier P (1995). Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacology 13, 117-127.
33. Emslie GJ, Rush AJ, Weinberg WA, et al (1997). A double blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 4, 1031-1037.
34. Emslie GJ, Heiligenstein JH, Wagner KD, et al (2002). Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41, 1205-1215.
35. Essau C, Dobson K (1999). Epidemiology of depressive disorders. In Essau C, Peterman F (Eds) Depressive disorders in children and adolescents: epidemiology, course and treatment, Aronson, Northvale, NJ.
36. Farchione TR, Moore GJ, Rosenberg DR (2002). Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol Psychiatry 52, 86-92.
37. Figueras G, Perez V, San Martino O, et al (1999). Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Biol Psychiatry 46, 518-524.
38. Fonnum F, Storm-Mathisen J, Divac I (1981). Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibers in rat brain. Neuroscience 6, 863-873.
39. Franz B, Kupfer DJ, Miewald JM, et al (1995). Growth hormone secretion timing in depression: Clinical outcome comparisons. Biol Psychiatry 38, 720-9.
40. Frodl T, Meisenzahl E, Zetzsche T, et al (2002a). Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry 51, 9, 708-14.
41. Frodl T, Meisenzahl EM, Zetzsche T, et al (2003). Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol Psychiatry 53, 4, 338-44.
42. Frodl T, Meisenzahl E, Zetzsche T, et al (2002b). Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 159, 1112-1118.
43. Giedd, A.C. Vaituzis, S.D. Hamburger, N, et al (1996). Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development ages 4-18 years. J Comp Neurol 366, 223-230.
44. Goldapple K, Segal Z, Garson C, et al (2004). Modulation of cortical-limbic pathways in major depression. Arch Gen Psychiatry 61, 34-41.
45. Gomez-Gil E, Gasto C, Diaz-Ricart M, et al (2002). Platelet 5-HT2A receptor-mediated induction of aggregation is not altered in major depression. Hum Psychopharmacol 17, 419-424.
46. Gonzalez JG, Elizondo G, Saldivar D, et al (1988). Pituitary gland growth during normal pregnancy: An in vivo study using magnetic resonance imaging. Am J Med 85, 217-20.
47. Goodwin GM (1996). Functional imaging, affective disorder and dementia. Br Med Bull 52, 495-512.
48. Halgren E, Walter RD, Cherlow DG, et al (1978). Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain 10, 83-117.
49. Hamakawa H, Kato T, Murashita J, et al (1998). Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 248, 53-58.
50. Hastings, R.V. Parsey, M.A. Oquendo, et al (2004). Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 29, 952-959.
51. Holsboer F, Lauer CJ, Schreiber W, et al (1995). Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62, 340-7.
52. Hyman SE (2000). The millennium of mind, brain, and behavior. Arch Gen Psychiatry 57, 88-89.
53. Kaufman MJ, Henry ME, Frederick B, et al (2003). Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: A proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 54, 534-539.
54. Kennedy SH, Evans KR, Kruger S, et al (2001). Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 158, 899-905.
55. Kessler RC, McGonagall KA, Nelson CB, et al (1994). Sex and depression in the national comorbidity Survey II: Cohort effects. J Affect disorder 30, 15-26.
56. Kessler RC, Avenevoli S, Merikangas KR (2001). Mood disorders in children and adolescents: An epidemiologic perspective. Biol Psychiatry 49, 1002-1014.
57. Kim JS, Hasller R, Hau P, et al (1977). Effect of frontal cortex ablation on striatal glutamic acid level in rat. Brain Res 132, 370-374.
58. Koller KJ, Zaczek R, Coyle JT (1984). N-acetyl-aspartyl-glutamate: Regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 43, 1136-1142.
59. Krishnan KR, Doraiswamy PM, Lurie SN, et al (1991). Pituitary size in depression. J Clin Endocrinol Metab 72, 256-9.
60. Lane RD, Reiman EM, Bradley MM, et al (1997). Neuroanatomical correlates of pleasant and unpleasant emotion. Neuropsychologia 35, 1437-1444.
61. LeDoux JE (1996). The Emotional Brain: The Mysterious Underpinnings of Emotional Life. Simon & Schuster, New York.
62. Lewinsohn PM, Fenn DS, Stanton AK, et al (1986). Relation of age at onset to duration of episode in unipolar depression. Psychol Aging 1, 63-68.
63. Lewinsohn PM, Hops H, Roberts RE, et al (1993a). Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 102, 133-144.
64. Lewinsohn PM, Rohde P, Seeley JR (1993b). Psychosocial characteristics of adolescents with a history of suicide attempt. J Am Acad Child Adolesc Psychiatry 32, 60-68.
65. MacMaster FP, Kusumakar V (2004a). Hippocampal volume in early onset depression. BMC Med 2, 2.
66. MacMaster FP, Kusumakar V (2004b). MRI study of the pituitary gland in adolescent depression. J Psychiar Res 38, 231-236.
67. MacMaster FP, Russell A, Mirza Y, et al (In Press). Pituitary Volume in treatment-naïve pediatric major depressive disorder. Biol Psychiatry.
68. MacMillan PR, Szeszko GJ, Moore R, et al (2003). Increased amygdala hippocampal volume ratios associated with severity of anxiety in pediatric major depression. J Child Adolesc Psychopharmacol 13, 65-73.
69. Maes M, Meltzer HY (1995). The serotonin hypothesis of major depression. In Bloom F, Kupfer D (Eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, NY.
70. Martin SD, Martin E, Rai SS, et al (2001). Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: Preliminary findings. Arch Gen Psychiatry 58, 641-648.
71. Mayberg HS (2002). Modulating limbic-cortical Circuits in depression: Targets of antidepressant treatments. Semin Clin Neuropsychiatry 7, 255-268.
72. Mayberg HS, Brannan SK, Mahurin RK et al (1997). Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8, 1057-1061.
73. Miller BL, Chang L, Booth R, et al (1996). In vivo 1H MRS choline: Correlation with in vitro chemistry/histology. Life Sci 58, 1929-1935.
74. Mirza Y, Tang J, Russell A, et al (2004). Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J Am Acad Child Adolesc Psychiatry 43, 341-348.
75. Moore CM, Breeze JL, Gruber SA, et al (2000). Choline, myoinositol and mood in bipolar disorder: A proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2, 207-216.
76. Nemeroff CB (1998). The neurobiology of depression. Sci Am 278, 42-9.
77. Nolan CL, Moore GJ, Madden R, et al (2002). Prefrontal cortical volume in childhood-onset major depression: Preliminary findings. Arch Gen Psychiatry 59, 2, 173-9.
78. Papez JW (1937). A proposed mechanism of emotion. Arch Neurol Psychiatry 38, 725-743.
79. Perez V, Be N, Celada P, et al (1998). Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments. J Clin Psychopharmacol 18, 222-230.
80. Pfleiderer B, Michael N, Erfurth A, et al (2003). Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 122, 185-192.
81. Pfluger, S. Weil, S. Weis, et al (1999). Normative volumetric data of the developing hippocampus in children based on magnetic resonance imaging. Epilepsia 40, 4, 414-423.
82. Phelps EA, Anderson AK (1997). Emotional memory: What does the amygdala do? Curr Biol 7, R311-R314.
83. Pine DS, Cohen E, Cohen P, et al (1999). Adolescent depressive symptoms as predictors of adult depression: Moodiness or mood disorder? Am J Psychiatry 156, 133-135.
84. Pine DS, Cohen P, Brook J (2001). Adolescent fears as predictors of depression. Biol Psychiatry 50, 9, 721-4.
85. Pouwels PJW, Frahm J (1998). Regional metabolite concentration in human brain as determined by quantitative localized proton MRS. Magn Reson Med 39, 53-60.
86. Provencher (2001). Automatic quantitation of localized in vivo H-1 spectra with LCModel. NMR in Biomedicine 14, 260-264.
87. Rao U, Dahl RE, Ryan ND, et al (1996). The relationship between longitudinal clinical course and sleep and cortisol changes in adolescent depression. Biol Psychiatry 40, 474-84.
88. Reisine T, Soubrie P, Artaud F, et al (1982). Application of L-glutamic acid and substance P to the substantia nigra modulates in vivo [3H] serotonin release in the basal ganglia of the cat. Brain Res 236, 317-327.
89. Renshaw PF, Lafer B, Babb SM, et al (1997). Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 41, 837-843.
90. Ressler KJ, Nemeroff CB (2000). Role of the serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12, 2-19.
91. Rosenberg DR, MacMaster FP, Keshavan MS, et al (2000). Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Adolesc Psychiatry 39, 1096-1103.
92. Rosenberg DR, MacMaster FP, Mirza Y, et al (2005). Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biol Psychiatry 58, 700-704.
93. Rosso IM, Cintron CM, Steingard RJ, et al (2005). Amygdala and hippocampus volumes in pediatric major depression. Biol Psychiatry 57, 1, 21-6.
94. Ryan ND, Varma D (1998). Child and adolescent mood disorders - experience with serotonin-based therapies. Biol Psychiatry 44, 5, 336-40.
95. Sallee FR, Hilal R, Dougherty D, et al (1998). Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline. J Am Acad Child Adolesc Psychiatry 37, 777-784.
96. Sanacora G, Kendell SF, Fenton L, et al (2004). Riluzole augmentation for treatment-resistant depression. Am J Psychiatry [letter] 161, 2132.
97. Sanacora G, Rothman DL, Mason G, et al (2003). Clinical studies implementing glutamate neurotransmission in mood disorders. Ann N Y Acad Sci 1003, 292-308.
98. Sheline YI, Wang PW, Gado MH, et al (1996). Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 93, 9, 3908-13.
99. Sheline YI, Sanghavi M, Mintun MA, et al (1999). Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19, 12, 503-443.
100. Sheline YI, Barch DM, Donnelly JM, et al (2001). Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: An fMRI study. Biol Psychiatry 50, 9, 651-8.
101. Sibson NR, Dhankhar A, Mason GF, et al (1997). In vivo 13CNMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc Natl Acad Sci USA 94, 2699-2704.
102. Soares JC, Mann JJ (1997a). The functional neuroanatomy of mood disorders. J Psychiatr Res 31, 4, 393-432.
103. Soares JC, Mann JJ (1997b). The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 41, 86-106.
104. Sonawalla S, Parikh R, Parikh F (1999). Compounds containing cytosolic choline in the basal ganglia: A potential biological marker of true drug response to fluoxetine. Am J Psychiatry 156, 1638-1640.
105. Stahl SM (1998). Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects. J Affect Disorder 51, 215-235.
106. Steffens DC, Byrum CE, McQuoid DR, et al (2000). Hippocampal volume in geriatric depression. Biol Psychiatry 48, 4, 301-9.
107. Steingard RJ, Renshaw PF, Hennen J, et al (2002). Smaller Frontal Lobe White Matter Volumes in Depressed Adolescents. Biol Psychiatry 52, 413.
108. Steingard RJ, Yurgelun-Todd DA, Hennen J, et al (2000). Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry 48, 1053-1061.
109. Takano K, Utsunomiya H, Ono H, et al (1999). Normal development of the pituitary gland: assessment with three-dimensional MR volumetry. AJNR Am J Neuroradiol 20, 312-5.
110. Tebartz van Elst L, Woermann F, Lemieux L, et al (2000). Increased amygdala volumes in female and depressed humans: A quantitative magnetic resonance imaging study. Neurosci Lett 281, 103-106.
111. Thomas KM, Drevets WC, Dahl RE, et al (2001). Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 58, 11, 1057-63.
112. The Treatment for Adolescents with Depression Study [TADS] Team (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial. JAMA 292, 807-820.
113. Vitiello B, Swedo S (2004). Antidepressant medications in children. N Engl J Med 350, 1489-1491.
114. Weissman MM, Wolk S, Goldstein RB, et al (1999). Depressed adolescents grown up. JAMA 281, 1707-1713.
115. Whittington CJ, Kendall T, Fonagy P, et al (2004). Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet 363, 1341-1345.
116. Yurgelun-Todd, Killgore WD, Cintron CB (2003). Cognitive correlates of medial temporal lobe development across adolescence: A magnetic resonance imaging study. Percept Mot Skills 96, 3-17.
117. Zarate CA, Quiroz J, Sporn J, et al (2002). Modulators of the glutamatergic system: A new class of antidepressants. Biol Psychiatry 353, 707-742.
118. Zarate CA, Du J, Quiroz J, et al (2003). Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: Role of the glutamatergic system. Ann NY Acad Sci 1003, 273-291.
119. Zarate CA, Payne JL, Quiroz J, et al (2004). An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 161, 171-174.